Nuevas vías de administración de inmunoterapia

Allergologia et Immunopathologia

Volumn 28, Issue 3, 2000, Pages 93-102

  Aragonés, A Martorell ^a  

^a NONE

Author keywords

Action mechanism; Clinical efficiency; Safety; Sublingual immunotherapy

Indexed keywords

EID: 0041116452     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bousquet J, Lockey RF, Mailing HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Supl. 44):1-42.
2. Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-41.
3. Malling HJ, Abeu-Nogueira J, Álvarez-Cuesta E, Björkstén B, Bousquet J, Caillot D et al. Position Paper. Local immunotherapy. Allergy 1998;53:933-44.
4. Curtis HH. The immunizing cure of hay fever. Med News (NY) 1900;77:16-8.
5. Möller C, Dreborg S, Lanner A, Bjorksten B. Oral immunotherapy of chindren with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986;41:271-9.
6. Björksten B, Möller C, Broberger U, Ahlstedt S, Dreborg S, Johansson SG et al. Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy 1986;41:290-5.
7. Scadding G, Brostoft J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allerg 1986;16:483-9.
8. De Weck AL. Oral o sublingual immunotherapy? a topic deserving new evaluation. ACI International 1996;8:19-29.
9. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102: 157-64.
10. Mowart AM,. The regulation of immune response to dietary proteins. Immunol Today 1987;8:93-6.
11. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral toleranca: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
12. Holt PG, Vines J, Britten D. Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses. Clin Allergy 1988;18:229-34.
13. Secrist H, DeKruyff RH, Umetsu DT. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;157:1434-47.
14. Mailing HJ. Sublingual immunotherapy. Clin Exp Allergy 1996;26:1228-31.
15. Motwani JG, Lipworth Bj. Clinical pharmacokinetics of drugs administered buccally and sublingually. Clin Pharmacokinet 1991;21:83-94.
16. Bagnasco M, Mariani G, Passalacqua G, Motta C, Bartolomei M, Falagiani P et al. Absortion and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997;100:122-9.
17. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite: a double-blind study. Allergol Immunopathol 1990;18:277-84.
18. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in parietaria pollen induced rhinitis: a double blind study. J Invest Allergol Clin Immunol 1995;5:25-30.
19. La Rosa M, Ranno M, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-32.
20. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-60.
21. Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma. A placebo controlled study. Ann Allergy Asthma Immunol 1999;82:485-90.
22. Piazza I, Bizzaro N. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Ann Allergy 1993;71:461-9.
23. Quirino T, lemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-61.
24. Hirsch T, Sahn M, Eupold W. Double-blind placebo controlled study of sublingual immunotherapy with house dust mite extract in children. Pediatr Allergy Immunol 1997;8:21-7.
25. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André C et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in paediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662-72.
26. Hordijk GJ, Antvelink JB, Luwema RA Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol 1998;26:234-40.
27. Purello-D'Ambrosio F, Gangemi S, Isola S, La Motta N, Puccinelli P, Parmiani S et al. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy 1999;54:968-73.
28. Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis.Allergy 1999;54:819-28.
29. Van Neerven RJJ. Immunological basis of specific allergy vaccination: the theoretical mechanisms using the mucosal route. Allergy 1999;54(Supl 54):8.
30. Blanco C, Quiralte J, Castillo R, Delgado J, Arteaga C, Barber D et al. Anaphylaxis after ingestión of wheat flour contaminated with mites. J Allergy Clin Immunol 1997;99:308-13.
31. Almagro E, Asensio O, Bartolomé JM et al. Estudio multicéntrico de farmacovigilancia de inmunoterapia sublingual en pacientes alérgicos. Allergol Immunopathol 1995;23:153-9.
32. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-3.
33. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-72.
34. Malling HJ, Weeke B. immunotherapy. EAACI Position Paper. Allergy 1993;48(Supl 14):9-35.
35. Feliziani V, Lattuada G, Partmiani S, Dall'aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study. Allergol Immunopathol 1995;23:224-30.
36. Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H. A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.
37. Passalacqua G, Albano M, Fregonese L, Riccio A, Prontato C, Mela GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-32.
38. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual swallow immunotherapy. A double blind placebo controlled trial of standardized five grass pollen extract in rhinitis. Allergy 1998;53:493-8.
39. Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S, Canonica GW. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J Allergy Clin Immunol 1999; 104: 964-8.
40. Yuksel H, Tanac R, Gousseinov A, Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. J Invest Allergol Clin Immunol 1999;9:305-13.
41. Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective verus sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol 1996;6:55-62.